Rockwell Medical is a biopharmaceutical company that offers products and services initially targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia.
The company is engaged in developing a proprietary renal drug therapy for treating iron deficiency in ESRD patients on dialysis.
Rockwell Medical chairman and CEO Robert Chioini said they are pleased to have executed this multi-year supply agreement with DaVita, further strengthening their business relationship.